Delta-Fly Pharma, Inc. (TYO:4598)
Japan · Delayed Price · Currency is JPY 145.00
-2.00 (-1.36%)
Jun 4, 2026, 3:30 PM JST
Delta-Fly Pharma Market Cap
Delta-Fly Pharma has a market cap or net worth of 1.76 billion as of June 4, 2026. Its market cap has decreased by -61.61% in one year.
Market Cap
1.76B
Enterprise Value
1.62B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
145.00
Market Cap Chart
Since October 12, 2018, Delta-Fly Pharma's market cap has decreased from 21.91B to 1.76B, a decrease of -91.95%. That is a compound annual growth rate of -28.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 4, 2026 | 1.76B | -71.57% |
| Dec 30, 2025 | 6.20B | 18.44% |
| Dec 30, 2024 | 5.24B | -37.32% |
| Dec 29, 2023 | 8.35B | 21.17% |
| Dec 30, 2022 | 6.89B | -14.46% |
| Dec 30, 2021 | 8.06B | 49.71% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 12, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TMS Co., Ltd. | 5.55B |
| Chiome Bioscience | 5.38B |
| PRISM BioLab Co.,LTD | 5.29B |
| Kohjin Bio | 5.19B |
| Linical | 4.97B |
| D. Western Therapeutics Institute | 4.05B |
| Transgenic Group | 3.86B |
| Ribomic | 3.64B |